MENU

RDNT Stock RadNet (RDNT, $48.18) Moving Average Convergence Divergence (MACD) Histogram turned negative on April 22, 2025

A.I.dvisor
at Tickeron.com
Loading...
RDNT - RadNet
MACD signal
Bearish Trend
Odds of DOWN Trend
Tickeron
MACD signal
Price: $48.18
Daily change: +$0.82 (+1.73%)
Daily volume: 559.3K
Capitalization: $3.6B
Industry: Medical Specialties
This is a Bearish indicator signaling RDNT's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 55 similar cases where RDNT's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:

RDNT sees MACD Histogram crosses below signal line

RDNT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on April 22, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 55 instances where the indicator turned negative. In of the 55 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RDNT as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDNT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RDNT broke above its upper Bollinger Band on April 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RDNT advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RDNT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.621) is normal, around the industry mean (23.907). RDNT's P/E Ratio (962.000) is considerably higher than the industry average of (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.924) is also within normal values, averaging (42.115).

View a ticker or compare two or three
RDNT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of medical imaging services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
1510 Cotner Avenue
Phone
+1 310 478-7808
Employees
8441
Web
http://www.radnet.com